| EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue |
Globe Newswire |
03/25 |
07:30 |
| Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer |
Globe Newswire |
03/25 |
07:30 |
| Global Industrial Chain Systems Market to Reach $5.2 Billion by 2030 as Manufacturing Automation and Food Processing Drive Steady Growth |
Globe Newswire |
03/25 |
07:29 |
| The better family SUV. Edmunds compares the Ford Explorer and Nissan Pathfinder |
AP Online |
03/25 |
07:27 |
| Cipher Digital Announces Business Updates |
Globe Newswire |
03/25 |
07:05 |
| Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9) |
Globe Newswire |
03/25 |
07:00 |
| Energous Wireless Power Solutions Reports Fiscal Year 2025 Results |
Globe Newswire |
03/25 |
07:00 |
| Notch Raises $30 Million to Bring Production-Ready AI Agents to Regulated Industries |
Globe Newswire |
03/25 |
07:00 |
| Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers |
Globe Newswire |
03/25 |
07:00 |
| Garrett Motion to hold Technology and Investor Day on Wednesday May 20, 2026 in New York City |
Globe Newswire |
03/25 |
07:00 |
| Winnebago Industries Reports Second Quarter Fiscal 2026 Results |
Globe Newswire |
03/25 |
07:00 |
| Picard Medical Reports Full Year 2025 Financial Results |
Globe Newswire |
03/25 |
07:00 |
| Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development |
Globe Newswire |
03/25 |
07:00 |
| Lightbridge to Serve on Industry Advisory Board of $6 Million DOE-Funded Project with Penn State |
Globe Newswire |
03/25 |
07:00 |
| NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset |
Globe Newswire |
03/25 |
07:00 |
| C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma |
Globe Newswire |
03/25 |
07:00 |
| Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval |
Globe Newswire |
03/25 |
07:00 |
| Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights |
Globe Newswire |
03/25 |
07:00 |
| Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) |
Globe Newswire |
03/25 |
06:48 |
| Wowza's Elliot Miller Joins Colorado PBS12 Board of Directors |
Globe Newswire |
03/25 |
06:38 |
| NOV Announces Expansion of Subsea Flexible Pipe Manufacturing Capacity to Support Growing Demand |
Globe Newswire |
03/25 |
06:30 |
| Amaze Highlights First Quarter 2026 Achievements and Upcoming Priorities in Letter to Shareholders |
Globe Newswire |
03/25 |
06:30 |
| SMR Lawsuit: NuScale Power Accused of Misrepresentations about ENTRA1 in Securities Fraud Class Action – Investors Notified to Contact BFA Law by April 20 |
Globe Newswire |
03/25 |
06:18 |
| Particula Launches the Digital Asset Risk Passport (PDARP) - Programmable Risk Infrastructure for On-chain Capital Markets |
Globe Newswire |
03/25 |
06:12 |
| VEON Highlights Uklon’s Expansion into Travel, Strengthening its Mobility Ecosystem in Ukraine |
Globe Newswire |
03/25 |
06:00 |
